Sign Up For Free
A study out of McMaster University that performed a systematic review of 17 randomized clinical trials involving 3,161 patients found that though medical cannabis is safe to use,  its role in the treatment of multiple sclerosis (MS) symptoms is not well-defined.

The study’s results come as a mixed bag for many medical cannabis users and even as another point of confusion. In its conclusions, it found there is a reduction of subjective spasticity, pain and bladder dysfunction in patients with MS, but no changes in objectively-measured spasticity.

The study also noted that in its comparisons of other treatments for each of these respective conditions, cannabis is considered a safe form of medication and the invasiveness and risks of other treatments should also be considered. 

Despite the limited amount of available research, the study stressed that cannabis can be considered a safe drug with no serious complications regarding withdrawal symptoms or drug dependence effects. 

Furthermore, the study pointed out there was no evidence of studies to evaluate the efficacy of cannabinoids vs other treatments in MS, and research into this area could shed more light on how cannabis can impact MS patients. 

Source: https://www.eurekalert.org/pub_releases/2018-10/jn-mmf100918.php

This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.


Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.